UniQure shares are trading higher after the company announced that its Hemophilia B Gene Therapy is unlikely to be causing liver cancer which was earlier reported in one patient.
UniQure shares are trading higher after the company announced that its Hemophilia B Gene Therapy is unlikely to be causing liver cancer which was earlier reported in one patient.
在該公司宣佈其血友病B基因療法不太可能導致肝癌後，UnQure的股價上漲。早些時候，有報道稱，這是一名患者患上的肝癌。
UniQure shares are trading higher after the company announced that its Hemophilia B Gene Therapy is unlikely to be causing liver cancer which was earlier reported in one patient.
在該公司宣佈其血友病B基因療法不太可能導致肝癌後，UnQure的股價上漲。早些時候，有報道稱，這是一名患者患上的肝癌。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。